NMR-resolved dynamics of C. difficile metabolism
NMR-resolved dynamics of C. difficile metabolism
批准号:
10574895
负责人:
LYNN BRY
金额:
$8.95万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-11-14 至 2024-10-31
关键词:
AblationAcidsAddressAlanineAlanine TransaminaseAminesAmino AcidsAnaerobic BacteriaAntibiotic TherapyAntibioticsBile AcidsBiomassCarbohydratesCarbonCellsClinicalClostridium difficileComplexConsumptionDiseaseEcosystemEnzymesEquilibriumEthanolaminesFermentationFerredoxinFormatesGenesGeneticGlutamate DehydrogenaseGlycolysisGrowthHospitalsInfectionL FormsLabelLyaseMagicMediatingMetabolicMetabolic PathwayMetabolismMethodsModelingMolecularMucous MembraneNitrogenNosocomial InfectionsNuclear Magnetic ResonanceNutrientNutrient availabilityOutcomeOxidasesOxidation-ReductionPathway interactionsPhasePhenotypePhysiologyProductionPyruvateRegulonResolutionRoleSerineSourceSurfaceSystemTherapeutic InterventionTimeToxinTransaminasesVirulenceamino acid metabolismcommensal microbescomputer frameworkdefined contributionenergy balancegenome-widegut colonizationimprovedin vivometabolic abnormality assessmentmetabolomicsmetatranscriptomicsmicrobiotamutantnitrogen metabolismnovelpathogenpreventive interventionprogramsrapid growthrecruitsmall moleculetherapeutic targettooltransamination
中文摘要
摘要:艰难梭菌是医院感染的主要病原菌
(HAI)。C. difficile可以消耗多种碳源,
支持肠道定植和感染。特别是糖酵解和Stickland氨基酸
发酵途径已被证明支持快速生长,这一发现也发生在
抗生素治疗通过去除竞争性的营养物质,
植物种。然而,专性厌氧细菌的代谢途径仍然存在,
定义不清,确定针对C的预防和治疗干预措施的能力有限。
difficile的核心生理学为了解决这些局限性,我们将采用100 - 200 μ mol/L的碳-13(13 C)NMR。
C.艰难梭菌的动态代谢,以告知基因组规模的代谢模型,并明确定义
产能糖酵解和氨基酸发酵的代谢整合点
途径。研究结果将在靶向遗传突变体中进行评估,并与以下组合进行评估:
可发酵碳源,以评估其对病原体生长和毒力的影响。
英文摘要
Abstract: Clostridioides difficile is the most prevalent cause of hospital associated infections
(HAIs). As an obligately anaerobic pathogen, C. difficile can consume diverse carbon sources to
support gut colonization and infection. In particular, glycolytic and Stickland amino acid
fermentation pathways have been shown to support rapid growth, a finding that also occurs after
antibiotic treatment elevates availability of these nutrient sources by removing competitive
commensal species. However, the metabolic pathways of obligately anaerobic bacteria remain
ill-defined, limiting capacity to identify preventive and therapeutic interventions that target C.
difficile’s core physiology. To address these limitations, we will employ carbon-13 (13C) NMR of
C. difficile’s dynamic metabolism to inform a genome-scale metabolic model and clearly define
metabolic integration points among energy-generating glycolytic and amino acid fermentation
pathways. Findings will be evaluated in targeted genetic mutants and with combinations of
fermentable carbon sources to evaluate their impact on pathogen growth and virulence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Commensal control of C. difficile virulence
-
批准号:10334540
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2021
-
负责人:LYNN BRY
-
依托单位:
Commensal control of C. difficile virulence
-
批准号:10211712
-
项目类别:
-
资助金额:$74.84万
-
财政年份:2021
-
负责人:LYNN BRY
-
依托单位:
Commensal control of C. difficile virulence
-
批准号:10556405
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2021
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8511759
-
项目类别:
-
资助金额:$37.33万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Crimson - i2b2 integration for high-throughput, scalable sample collection
-
批准号:7698313
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8114180
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8304230
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8239799
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:7932782
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Crimson - i2b2 integration for high-throughput, scalable sample collection
-
批准号:7918185
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:7738696
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Protective role of cross-reactive anti-enteric antibody
-
批准号:6875700
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2004
-
负责人:LYNN BRY
-
依托单位:
Protective role of cross-reactive anti-enteric antibody
-
批准号:6766062
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2004
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:7096555
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6781714
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6922803
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6680658
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Gnotobiotics, Microbiology and Metagenomics Core
-
批准号:10049386
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
GNOTOBIOTICS AND MICROBIOLOGY CORE
-
批准号:8565001
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
Gnotobiotics, Microbiology and Metagenomics Core
-
批准号:10378466
-
项目类别:
-
资助金额:$27.75万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: